Statistics: Applied biochemistry and biotechnology
Geo Map
Region
#
NA - North America
9
AS - Asia, other
8
AF - Africa
6
EU - Europe
6
Unknown
106
Total
135
Country
#
US - United States of America
9
CN - China
5
EG - Egypt
3
KR - Korea
3
CI - Cote d'Ivoire
2
DE - Germany
2
FI - Finland
2
RU - Russian Federation
2
SN - Senegal
1
Unknown
106
Total
135
City
#
Mountain View
6
Seoul
3
Zhengzhou
2
Abidjan
1
Al Fayyum
1
Alexandria
1
Buffalo
1
Béoumi
1
Cairo
1
Guangzhou
1
other
117
Total
135
Most viewed items
#
ID: 173337 - Molecular and Biological Characterization of a Prepared Recombinant Human Interferon Alpha 2b Isoform
74
Total
74
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2019
0 0
0 0 0 0
2 4 0 1
0 0
7
2020
1 0
2 0 0 3
1 0 0 0
0 0
7
2021
0 0
0 0 2 2
0 3 2 1
2 7
19
2022
1 2
2 1 1 1
2 2 0 6
3 5
26
2023
5 0
0 0 3 1
1 3 6 1
2 16
38
2024
4 2
2 6 0 5
2 0 0 0
0 0
21
Ever
135
Geo Map
Region | # |
---|---|
NA - North America | 9 |
AS - Asia, other | 8 |
AF - Africa | 6 |
EU - Europe | 6 |
Unknown | 106 |
Total | 135 |
Country | # |
---|---|
US - United States of America | 9 |
CN - China | 5 |
EG - Egypt | 3 |
KR - Korea | 3 |
CI - Cote d'Ivoire | 2 |
DE - Germany | 2 |
FI - Finland | 2 |
RU - Russian Federation | 2 |
SN - Senegal | 1 |
Unknown | 106 |
Total | 135 |
City | # |
---|---|
Mountain View | 6 |
Seoul | 3 |
Zhengzhou | 2 |
Abidjan | 1 |
Al Fayyum | 1 |
Alexandria | 1 |
Buffalo | 1 |
Béoumi | 1 |
Cairo | 1 |
Guangzhou | 1 |
other | 117 |
Total | 135 |
Most viewed items | # |
---|---|
ID: 173337 - Molecular and Biological Characterization of a Prepared Recombinant Human Interferon Alpha 2b Isoform | 74 |
Total | 74 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 0 | 1 | 0 | 0 | 7 |
2020 | 1 | 0 | 2 | 0 | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 7 |
2021 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 3 | 2 | 1 | 2 | 7 | 19 |
2022 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 0 | 6 | 3 | 5 | 26 |
2023 | 5 | 0 | 0 | 0 | 3 | 1 | 1 | 3 | 6 | 1 | 2 | 16 | 38 |
2024 | 4 | 2 | 2 | 6 | 0 | 5 | 2 | 0 | 0 | 0 | 0 | 0 | 21 |
Ever | 135 |